Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Conversation logo

In 2019, about 463 million people suffered from diabetes and over 2 million people lost their lives to its complications, including common cardiovascular complications such as heart attacks and strokes. We need to discover new ways to combat diabetes and its complications to improve the quality of life and prolong the survival of millions of patients.

High blood sugar is toxic for blood vessels and this toxic effect is believed to be responsible for the cardiovascular complications of diabetes, such as heart attacks and strokes. Insulin is a common treatment used to reduce blood sugar levels in people with diabetes – usually administered with an insulin pen or pump.

But much to scientists’ surprise, clinical trials have shown that insulin treatment doesn’t reduce the risk of heart attacks and strokes, even though it greatly reduces sugar in the bloodstream. This means that controlling blood sugar with insulin is not enough to prevent damage in the blood vessels of patients with diabetes. Why does this happen? What are we missing in this chain of events?

Read the full article on The Conversation website, written by Ioannis Akoumianakis and Charalambos Antoniades (Radcliffe Department of Medicine)

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Review highlights risk factors associated with violence in schizophrenia

Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).

An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections

First comprehensive analysis of global impact of antimicrobial resistance (AMR) estimates resistance itself caused 1.27 million deaths in 2019 - more deaths than HIV/AIDS or malaria - and that antimicrobial-resistant infections played a role in 4.95 million deaths.

Attention and memory deficits persist for months after recovery from mild Covid

Researchers from Oxford’s Department of Experimental Psychology and Nuffield Department of Clinical Neurosciences have shown that people who have had Covid but don’t complain of long Covid symptoms in daily life nevertheless can show degraded attention and memory for up to 6-9 months.

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.

New book expands the horizons of brain research

A pioneering book from Professor Zoltán Molnár and Yale Professors Tamas Horvath and Joy Hirsch to be released on 1 February 2022 addresses the fundamental relationship between the body, brain and behaviour.

New research sheds light on how ultrasound could be used to treat psychiatric disorders

A new study in macaque monkeys has shed light on which parts of the brain support credit assignment processes (how the brain links outcomes with its decisions) and, for the first time, how low-intensity transcranial ultrasound stimulation (TUS) can modulate both brain activity and behaviours related to these decision-making and learning processes.